April 27, 2020 | 9:51am | Updated April 27, 2020 | 11:13am The US Centers for Disease Control and Prevention has updated its list of symptoms for the coronavirus, adding six new possible indicators of the deadly bug. The CDC now recognizes chills, repeated shaking with chills, muscle pain, headache, sore throat and new loss…
Susan Miller, USA TODAY Published 11:49 a.m. ET April 26, 2020 | Updated 12:24 p.m. ET April 26, 2020CLOSE The secret to fighting COVID-19 could be in recovered patients. Here's how antibodies could lead to a treatment for those fighting coronavirus. USA TODAYChills, repeated shaking with chills, muscle pain, headache, sore throat and a loss…
Doctors discovering new complications of COVID-19 The Centers for Disease Control and Prevention has added six new symptoms to its list of possible signs of the coronavirus. Previously, the CDC only noted fever, cough and shortness of breath as symptoms. The agency has updated its list to include: chills, repeated shaking with chills, muscle pain,…
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.The Centers for Disease Control has tripled the number of symptoms that could be indicators of coronavirus, including muscle pain, headache and new loss of taste or smell.DO THESE ENVIRONMENTAL FACTORS WEAKEN DISEASE?WGME reported Thursday that the CDC previously listed three…
(WSVN) - There could be a big breakthrough in a South Florida lab in the fight against the coronavirus. A team of doctors have said they are one step closer to developing a vaccine. Well before we all started social distancing, the husband and wife power team of doctors, Hyeryun Choe and Michael Farzan, had…
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years
KFF Health News chief Washington correspondent Julie Rovner discussed Affordable Care Act subsidies on Crooked Media’s What a Day on Dec. 10 and on Slate’s What Next on Dec. 9. Click here to hear Rovner on What a Day. Click here to hear Rovner on What Next. KFF Health News Washington health policy reporter Amanda